Stock listing
Frankfurt:ABG Cencora, Inc. Aktie
German listing (Frankfurt) of Cencora, Inc. · home listing NYSE:COR
Follow Cencora, Inc. into a list and get an email when it puts out news.
Share price · FWB:ABG
€307.30 EUR -7.40 (-2.4%)
Close on Nov 20, 2026
- Day range
- €307.30 – €307.30 EURNov 20, 2026
- Market cap
- €58.64B EURAt the close on Nov 20, 2026 · price × 190.8M shares outstanding
- 52-week range
- €212.59 – €330.04 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €12,992 EURMedian day 0 shares · 31 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:COR · Home | $339.09 USD | -9.22 (-2.6%) | 1,231,459 | $344.31 | $348.57 | $337.88 | $348.31 | Close on Nov 20, 2026 |
| LSE:0HF3 | $348.60 USD | -2.77 (-0.8%) | 30 | $348.50 | $351.89 | $344.72 | $351.37 | Close on Nov 18, 2026 |
| B3:C1CO34 | 775.73 BRL | 0.00 (0.0%) | — | 775.73 | 775.73 | 775.73 | 775.73 | Close on Nov 19, 2026 |
| Frankfurt:ABG | €307.30 EUR | -7.40 (-2.4%) | — | €307.30 | €307.30 | €307.30 | €314.70 | Close on Nov 20, 2026 |
| Dusseldorf:ABG | €311.00 EUR | +0.70 (+0.2%) | — | €310.50 | €312.60 | €310.50 | €310.30 | Close on Nov 20, 2026 |
| Munich:ABG | €311.35 EUR | -7.90 (-2.5%) | — | €311.35 | €311.35 | €311.35 | €319.25 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:ABG · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €299.34 | -12.43 | -4.0% | €300.90 | €301.20 | €298.93 | 0 | |
| €311.77 | +9.143 | +3.0% | €312.07 | €312.13 | €310.83 | 1 | |
| €302.63 | +4.152 | +1.4% | €301.37 | €303.05 | €301.06 | 610 | |
| €298.48 | +6.24 | +2.1% | €298.48 | €298.48 | €298.48 | 0 | |
| €292.24 | -7.906 | -2.6% | €292.94 | €293.31 | €291.81 | 0 | |
| €300.14 | +9.973 | +3.4% | €295.16 | €302.00 | €294.86 | 52 | |
| €290.17 | +0.307 | +0.1% | €290.17 | €290.77 | €289.77 | 8 | |
| €289.86 | -2.175 | -0.7% | €290.67 | €291.61 | €288.47 | 124 | |
| €292.04 | -2.531 | -0.9% | €292.11 | €292.24 | €291.91 | 31 | |
| €294.57 | -1.462 | -0.5% | €292.95 | €294.71 | €289.63 | 31 | |
| €296.03 | -3.305 | -1.1% | €296.76 | €296.78 | €294.48 | 45 | |
| €299.34 | +0.082 | 0.0% | €299.27 | €299.40 | €299.25 | 0 | |
| €299.25 | -0.784 | -0.3% | €299.94 | €299.95 | €299.25 | 29 | |
| €300.04 | +1.544 | +0.5% | €300.80 | €305.86 | €300.04 | 0 | |
| €298.49 | -2.035 | -0.7% | €301.39 | €301.41 | €297.45 | 30 | |
| €300.53 | +3.20 | +1.1% | €301.23 | €302.15 | €299.60 | 0 | |
| €297.33 | +6.633 | +2.3% | €297.33 | €297.33 | €297.33 | 30 | |
| €290.70 | +3.569 | +1.2% | €290.70 | €290.70 | €290.70 | 0 | |
| €287.13 | -0.717 | -0.2% | €287.13 | €287.13 | €287.13 | 0 | |
| €287.84 | +6.768 | +2.4% | €287.84 | €287.84 | €287.84 | 0 | |
| €281.08 | +2.219 | +0.8% | €281.08 | €281.08 | €281.08 | 0 | |
| €278.86 | +0.063 | 0.0% | €278.86 | €278.86 | €278.86 | 104 | |
| €278.79 | +1.152 | +0.4% | €278.79 | €278.79 | €278.79 | 0 | |
| €277.64 | +1.885 | +0.7% | €277.64 | €277.64 | €277.64 | 0 | |
| €275.76 | +3.821 | +1.4% | €275.76 | €275.76 | €275.76 | 0 | |
| €271.94 | +11.17 | +4.3% | €271.94 | €271.94 | €271.94 | 210 | |
| €260.77 | -7.412 | -2.8% | €260.77 | €260.77 | €260.77 | 8 | |
| €268.18 | +4.038 | +1.5% | €268.18 | €268.18 | €268.18 | 0 | |
| €264.14 | -3.827 | -1.4% | €264.14 | €264.14 | €264.14 | 0 | |
| €267.97 | -1.17 | -0.4% | €267.97 | €267.97 | €267.97 | 0 | |
| €269.14 | -0.531 | -0.2% | €268.90 | €269.28 | €267.90 | 100 | |
| €269.67 | -2.619 | -1.0% | €269.67 | €269.67 | €269.67 | 0 | |
| €272.29 | +0.894 | +0.3% | €272.29 | €272.29 | €272.29 | 30 | |
| €271.39 | +3.918 | +1.5% | €271.39 | €271.39 | €271.39 | 0 | |
| €267.47 | +1.492 | +0.6% | €267.47 | €267.47 | €267.47 | 0 | |
| €265.98 | -7.411 | -2.7% | €265.98 | €265.98 | €265.98 | 60 | |
| €273.39 | -2.185 | -0.8% | €273.39 | €273.39 | €273.39 | 38 | |
| €275.58 | -3.235 | -1.2% | €275.58 | €275.58 | €275.58 | 0 | |
| €278.81 | +4.047 | +1.5% | €278.81 | €278.81 | €278.81 | 0 | |
| €274.77 | -0.559 | -0.2% | €274.77 | €274.77 | €274.77 | 4 | |
| €275.33 | +0.774 | +0.3% | €273.44 | €278.24 | €272.46 | 8 | |
| €274.55 | -2.356 | -0.9% | €274.55 | €274.55 | €274.55 | 0 | |
| €276.91 | -2.879 | -1.0% | €276.91 | €276.91 | €276.91 | 515 | |
| €279.79 | -1.661 | -0.6% | €279.79 | €279.79 | €279.79 | 0 | |
| €281.45 | -6.831 | -2.4% | €281.45 | €281.45 | €281.45 | 0 | |
| €288.28 | -0.933 | -0.3% | €288.28 | €288.28 | €288.28 | 2 | |
| €289.21 | +7.804 | +2.8% | €289.21 | €289.21 | €289.21 | 0 | |
| €281.41 | +5.652 | +2.0% | €281.41 | €281.41 | €281.41 | 0 | |
| €275.76 | +3.393 | +1.2% | €275.76 | €275.76 | €275.76 | 38 | |
| €272.36 | -0.822 | -0.3% | €272.36 | €272.36 | €272.36 | 0 | |
| €273.18 | -4.197 | -1.5% | €273.18 | €273.18 | €273.18 | 400 | |
| €277.38 | -1.528 | -0.5% | €277.38 | €277.38 | €277.38 | 62 | |
| €278.91 | +3.305 | +1.2% | €278.91 | €278.91 | €278.91 | 0 | |
| €275.60 | +5.666 | +2.1% | €275.60 | €275.60 | €275.60 | 0 | |
| €269.94 | +3.835 | +1.4% | €269.94 | €269.94 | €269.94 | 0 | |
| €266.10 | -4.295 | -1.6% | €266.10 | €266.10 | €266.10 | 40 | |
| €270.40 | +0.718 | +0.3% | €270.40 | €270.40 | €270.40 | 0 |
Splits
2 splits since 2005 · FWB:ABG · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 2-for-1 | Split |
- Ticker
- Frankfurt:ABG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 4, 2026
Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results
Latest earnings call · Nov 4, 2026
Cencora (NYSE:COR) Q4 2026 Earnings Call
Replay and transcript
Latest deck · Nov 4, 2026
Q4 2026 Earnings Presentation
Earnings · 23 slides
Latest news
Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results
Nov 4, 2026
Closed €302.63 (+1.4%) on Nov 4, 2026
Cencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus
Nov 4, 2026
Closed €302.63 (+1.4%) on Nov 4, 2026
Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology
Oct 21, 2026
Closed €299.25 (-0.3%) on Oct 21, 2026
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release
Oct 2, 2026
Closed €271.94 (+4.3%) on Oct 2, 2026
Cencora Elects Robert E. Sanchez to Its Board of Directors
Sep 25, 2026
Closed €269.14 (-0.2%) on Sep 25, 2026
Q3 2026 Cencora Earnings Presentation
Aug 5, 2026
Closed €262.79 (-1.1%) on Aug 5, 2026
Cencora Reports Fiscal 2026 Third Quarter Results
Aug 5, 2026
Closed €262.79 (-1.1%) on Aug 5, 2026
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
Jul 1, 2026
Closed €252.07 (+2.9%) on Jul 2, 2026
Cencora Announces Samantha Hammock as Chief Human Resources Officer
Jun 15, 2026
Closed €244.40 (+1.8%) on Jun 16, 2026
Cencora to Support U.S. Distribution of Kite’s CAR T-Cell Therapies
Jun 2, 2026
Closed €225.06 (-1.5%) on Jun 2, 2026
Cencora, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 34 in the last 12 months · 52 in all · newest Nov 4, 2026 · oldest 2025
- Calls
- 50 calls with a replay · 50 with a transcript · latest Nov 4, 2026
- Decks
- 61 decks · latest Nov 4, 2026
Where Cencora, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:COR · Home listing | NYSE | United States | USD |
| gettex:ABG | gettex | Germany | EUR |
| Tradegate:ABG | Tradegate | Germany | EUR |
| VIE:ABC | Vienna | Austria | EUR |
| LS Exchange:766149 | LS Exchange | Germany | EUR |
| Lang & Schwarz:766149 | Lang & Schwarz | Germany | EUR |
| LSE:0HF3 | LSE | United Kingdom | USD |
| BMV:COR | BMV | Mexico | MXN |
| BOATS:COR | BOATS | United States | USD |
| Milan:1COR | Milan | Italy | EUR |
| B3:C1CO34 | B3 | Brazil | BRL |
| BIVA:COR | BIVA | Mexico | MXN |
| Frankfurt:ABG · This page | Frankfurt | Germany | EUR |
| Stuttgart:ABG | Stuttgart | Germany | EUR |
| Dusseldorf:ABG | Dusseldorf | Germany | EUR |
| Munich:ABG | Munich | Germany | EUR |
| BX Swiss:ABG | BX Swiss | Switzerland | CHF |
| Hamburg:ABG | Hamburg | Germany | EUR |
| Hanover:ABG | Hanover | Germany | EUR |
| Xetra:ABG | Xetra | Germany | EUR |
Valuation
P/E 24.6× against a median of 25.7×: 5th lowest of 11 Health care services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $73.62B USD
- P/E
- 24.6×
- EV/sales
- 0.2×
- EV/EBITDA
- 18.0×
- Price/book
- 21.2×
- Gross margin
- 4.0%
- Operating margin
- 0.9%
- Net margin
- 0.8%
- Debt to equity
- 3.8×
- Beta vs S&P 500
- 0.12
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cencora, Inc. · NYSE:COR | US$64.71B | US$73.62B | 24.6× | 0.2× | 18.0× | 21.2× | 0.8% | 3.8× | 0.12 |
| McKesson Corporation · NYSE:MCK | US$123.5B | US$126.2B | 26.3× | 0.3× | 18.0× | n/a | 1.1% | n/a | -0.11 |
| HCA Healthcare, Inc. · NYSE:HCA | US$99.34B | US$148.9B | 14.7× | 1.9× | n/a | n/a | 8.6% | n/a | 0.23 |
| Cardinal Health, Inc. · NYSE:CAH | US$63.17B | US$59.79B | 34.8× | 0.2× | 16.3× | n/a | 0.7% | n/a | 0.04 |
| Labcorp Holdings Inc. · NYSE:LH | US$29.81B | US$35.40B | 29.7× | 2.4× | n/a | 3.4× | 6.9% | 0.7× | 0.33 |
| Quest Diagnostics Incorporated · NYSE:DGX | US$28.42B | US$33.17B | 25.2× | 2.8× | 14.4× | 3.7× | 9.5% | 0.7× | -0.03 |
| Tenet Healthcare Corporation · NYSE:THC | US$21.19B | US$18.68B | 7.3× | 0.8× | 3.0× | 3.9× | 13.1% | 0.0× | 0.60 |
| IHH Healthcare Bhd. · MYX:IHH | US$16.98B | US$20.21B | 31.1× | 3.1× | 14.6× | 2.2× | 8.4% | 0.5× | n/a |
| Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP | US$14.28B | US$14.90B | 59.0× | 5.0× | 22.8× | 12.5× | 8.1% | 0.8× | n/a |
| Encompass Health Corporation · NYSE:EHC | US$13.19B | US$13.16B | 20.5× | 2.1× | n/a | 4.9× | 10.2% | 0.0× | 0.03 |
| Rede D'Or Sao Luiz SA · BMFBOVESPA:RDOR3 | US$13.12B | US$14.96B | 16.9× | 1.5× | 6.2× | 3.6× | 7.9% | 2.5× | n/a |
| Median of the others | US$24.80B | US$26.69B | 25.7× | 2.0× | 14.6× | 3.7× | 8.2% | 0.7× | 0.04 |
Forecasts
7 strong buy · 3 buy · 4 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 388.25 USD · Analysts' mean
- EPS, year to Sep 2027
- 19.64 · 9 analysts
- Revenue, year to Sep 2027
- 351.8B · 8 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Robert P. Mauch | President and Chief Executive Officer |
| Eva Boratto | Executive Vice President and Chief Financial Officer |
| Matt Glucksmann | SVP and President, Health Systems |
| Richard Tremonte | EVP and President, Global Specialty Pharmaceuticals and Operations |
| Tim Cernohous | Senior Vice President and President, Retail Pharmacy and Alternate Care |
| Elizabeth Campbell | Executive Vice President and Chief Legal Officer |
| Melissa O'Brien | Vice President, Investor Relations |
| François Mandeville | Executive Vice President and Chief Strategy and M&A Officer |
| Juan Guerra | Executive Vice President, Alliance Healthcare |
| Pawan Verma | Executive Vice President and Chief Data and Information Officer |
| Sam Hammock | Executive Vice President and Chief Human Resources Officer |
Board
| Director | Role |
|---|---|
| Robert E. Sanchez | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Cencora (NYSE:COR) Q4 2026 Earnings Call | Wed, Nov 04, 2026 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q3 2026 Earnings Call | Wed, Aug 05, 2026 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q2 2026 Earnings Call | Wed, May 06, 2026 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q1 2026 Earnings Call | Wed, Feb 04, 2026 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q4 2025 Earnings Call | Wed, Nov 05, 2025 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q3 2025 Earnings Call | Wed, Aug 06, 2025 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q2 2025 Earnings Call | Wed, May 07, 2025 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q1 2025 Earnings Call | Wed, Feb 05, 2025 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q4 2024 Earnings Call | Wed, Nov 06, 2024 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q3 2024 Earnings Call | Wed, Jul 31, 2024 · 8:30 AM ET | Replay |
All 50 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 4, 2026 · Before open | +4.0% |
| Q3 2026 | Aug 5, 2026 · Before open | +3.6% |
| Q2 2026 | May 6, 2026 · Before open | −17.4% |
| Q1 2026 | Feb 4, 2026 · Before open | −8.8% |
| Q4 2025 | Nov 5, 2025 · Before open | +2.8% |
| Q3 2025 | Aug 6, 2025 · Before open | −2.9% |
| Q2 2025 | May 7, 2025 · Before open | +4.7% |
| Q1 2025 | Feb 5, 2025 · Before open | +0.7% |
| Q4 2024 | Nov 6, 2024 | +5.9% |
| Q3 2024 | Jul 31, 2024 · Before open | +3.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2024 | May 1, 2024 · Before open | −4.1% |
| Q1 2024 | Jan 31, 2024 · Before open | +5.5% |
| Q4 2023 | Nov 2, 2023 · Before open | +2.6% |
| Q3 2023 | Aug 2, 2023 · Before open | +1.2% |
| Q2 2023 | May 2, 2023 · Before open | +1.4% |
| Q1 2023 | Feb 1, 2023 · Before open | −4.7% |
| Q4 2022 | Nov 3, 2022 · Before open | +2.0% |
| Q3 2022 | Aug 3, 2022 · Before open | −2.7% |
| Q2 2022 | May 4, 2022 · Before open | +4.0% |
| Q1 2022 | Feb 2, 2022 · Before open | −1.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q4 2026 Earnings Presentation | Earnings | 23 slides | Nov 4, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 18 slides | Aug 5, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 18 slides | May 6, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 20 slides | Feb 4, 2026 |
| 44th Annual J.P. Morgan Healthcare Conference (January 2026) | Conference | 13 slides | Jan 12, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 24 slides | Nov 5, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 18 slides | Aug 6, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 18 slides | May 7, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 19 slides | Feb 5, 2025 |
| 43rd Annual J.P. Morgan Healthcare Conference (January 2025) | Conference | 15 slides | Jan 13, 2025 |
Show 50 decks
This page holds 50 of 61 decks. Open Decks
Financings
| Raise | Date |
|---|---|
| Public offering of senior notes Announced: Citigroup Global Markets Inc. +3 Dealers: Citigroup Global Markets Inc. (co-lead), J.P. Morgan Securities LLC (co-lead), BofA Securities, Inc. (co-lead), Wells Fargo Securities, LLC (co-lead) Use of proceeds: Repay amounts under the 364-Day Term Credit Agreement used to fund part of the OneOncology acquisition; any remainder for general corporate purposes | Feb 10, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 321.3B | 294.0B | 262.2B | 238.6B | 214.0B | 189.9B | 179.6B | 167.9B | 153.1B | 146.8B |
| Cost of revenue | 309.9B | 284.0B | 253.2B | 230.3B | 207.0B | 184.7B | 174.5B | 163.3B | 148.6B | 142.6B |
| Gross profit | 11.5B | 9.91B | 8.96B | 8.30B | 6.94B | 5.19B | 5.14B | 4.61B | 4.55B | 4.27B |
| Selling, general and administrative | 6.49B | 5.66B | 5.31B | 4.85B | 3.59B | 2.77B | 2.66B | 2.46B | 2.13B | 2.09B |
| Operating income | 2.63B | 2.18B | 2.34B | 2.37B | 2.35B | -5.14B | 1.11B | 1.44B | 1.06B | 1.53B |
| Depreciation and amortization | 1.05B | 1.09B | 963.9M | 693.9M | 505.2M | 391.1M | 462.4M | 465.1M | 397.6M | 364.7M |
| EBITDA | 3.68B | 3.27B | 3.30B | 3.06B | 2.86B | -4.74B | 1.57B | 1.91B | 1.46B | 1.89B |
| Interest expense | 419.8M | 248.7M | 275.6M | 232.0M | 182.5M | 158.5M | 195.5M | 189.6M | 149.0M | 144.3M |
| Income before tax | 2.26B | 2.00B | 2.16B | 2.18B | 2.22B | -5.29B | 967.1M | 1.18B | 917.9M | 1.39B |
| Income tax | 690.5M | 484.7M | 428.3M | 516.5M | 677.3M | -1.89B | 113.0M | -438.5M | 553.4M | -37.0M |
| Net income | 1.55B | 1.51B | 1.75B | 1.70B | 1.54B | -3.41B | 855.4M | 1.66B | 364.5M | 1.43B |
| Earnings per share, basic | 8.02 | 7.60 | 8.62 | 8.15 | 7.48 | -16.65 | 4.07 | 7.61 | 1.67 | 6.73 |
| Earnings per share, diluted | 7.96 | 7.53 | 8.53 | 8.04 | 7.39 | -16.65 | 4.04 | 7.53 | 1.64 | 6.32 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.36B | 3.13B | 2.59B | 3.39B | 2.55B | 4.60B | 3.37B | 2.49B | 2.44B | 2.74B |
| Short-term investments | 0 | 372.9M | 26.1M | |||||||
| Receivables | 25.2B | 23.9B | 20.9B | 18.5B | 18.2B | 13.8B | 12.4B | 11.3B | 10.3B | 9.18B |
| Inventory | 20.5B | 19.0B | 17.5B | 15.6B | 15.4B | 12.6B | 11.1B | 11.9B | 11.5B | 10.7B |
| Current assets | 52.2B | 47.7B | 42.8B | 39.6B | 38.8B | 33.1B | 28.1B | 25.9B | 24.3B | 22.9B |
| Property, plant and equipment | 2.54B | 2.18B | 2.14B | 2.14B | 2.16B | 1.48B | 1.77B | 1.89B | 1.80B | 1.53B |
| Goodwill | 13.7B | 9.32B | 9.57B | 8.50B | 9.03B | 6.71B | 6.71B | 6.66B | 6.04B | 5.99B |
| Total assets | 76.6B | 67.1B | 62.6B | 56.6B | 57.3B | 44.3B | 39.2B | 37.7B | 35.3B | 33.6B |
| Accounts payable | 54.7B | 50.9B | 45.8B | 40.2B | 38.0B | 31.7B | 28.4B | 26.8B | 25.4B | 23.9B |
| Current liabilities | 57.8B | 54.3B | 48.8B | 43.5B | 41.4B | 33.9B | 29.6B | 27.9B | 26.8B | 25.3B |
| Long-term debt | 7.54B | 3.81B | 4.15B | 4.63B | 6.38B | 3.62B | 4.03B | 4.16B | 3.43B | 3.58B |
| Total debt | 7.66B | 4.39B | 4.79B | 5.70B | 6.68B | 4.12B | 4.17B | 177.5M | 3.44B | 4.19B |
| Total liabilities | 74.8B | 66.3B | 61.9B | 56.5B | 56.8B | 45.1B | 36.5B | 35.0B | 33.3B | 31.5B |
| Shareholders' equity | 1.51B | 645.9M | 522.0M | -211.6M | 223.4M | -1.02B | 2.88B | 2.93B | 2.06B | 2.13B |
| Shares outstanding | 193.9M | 194.9M | 200.8M | 206.2M | 208.1M | 204.2M | 206.8M | 213.2M | 218.0M | 220.1M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 3.88B | 3.48B | 3.91B | 2.70B | 2.67B | 2.21B | 2.34B | 1.41B | 1.50B | 3.18B |
| Capital spending | -668.0M | -487.2M | -458.4M | -496.3M | -438.2M | -369.7M | -310.2M | -336.4M | -466.4M | -464.6M |
| Free cash flow | 3.21B | 3.00B | 3.45B | 2.21B | 2.23B | 1.84B | 2.03B | 1.07B | 1.04B | 2.71B |
| Cash from investing | -4.98B | -618.1M | -2.60B | -368.4M | -6.14B | -379.9M | -375.8M | -1.11B | -498.0M | -3.17B |
| Cash from financing | 2.25B | -2.33B | -2.22B | -1.75B | 1.95B | -603.6M | -1.09B | -242.9M | -1.31B | 565.1M |
| Dividends paid | -437.1M | -416.2M | -398.8M | -391.7M | -366.6M | -343.6M | -339.0M | -333.0M | -320.3M | -288.5M |
| Share buybacks | -435.5M | -1.49B | -1.18B | -483.7M | -82.2M | -420.4M | -674.0M | -639.2M | -329.9M | -2.27B |
| Change in cash | 1.10B | 545.0M | -840.6M | 523.4M | -1.53B | 1.22B | 881.7M | 57.4M | -306.7M | 574.4M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 4, 2026 | Current report | SEC |
| 8-K · Current report | Nov 4, 2026 | Results | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 8-K · Current report | Oct 21, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 1, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 25, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 11, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 4, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 1, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 24, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 14, 2026 | Management or board change | SEC |
| 8-K · Current report | Aug 12, 2026 | Current report | SEC |
| 144 · Notice of proposed sale | Aug 6, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 5, 2026 | Results | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 30, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2026 | Insider trade | SEC |
| 11-K · Annual report of an employee plan | Jun 18, 2026 | Annual report | SEC |
| 8-K · Current report | Jun 15, 2026 | Management or board change | SEC |
| 8-K · Current report | May 29, 2026 | Management or board change | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2026 | Results | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 23, 2026 | Current report | SEC |
| 8-K · Current report | Mar 17, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 6, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | Feb 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 18, 2026 | Other filings | SEC |
| 8-K · Current report | Feb 18, 2026 | Current report | SEC |
| 8-K · Current report | Feb 13, 2026 | Material contract | SEC |
| 424B2 · Prospectus | Feb 11, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 11, 2026 | Current report | SEC |
| FWP · Free writing prospectus | Feb 10, 2026 | Offer document | SEC |
| 424B5 · Prospectus | Feb 10, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 10, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Feb 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Feb 4, 2026 | Results | SEC |
| 3 · Initial statement of ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 22, 2026 | Insider trade | SEC |
| ARS · Annual report to shareholders | Jan 22, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Jan 22, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jan 22, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jan 22, 2026 | Management or board change | SEC |
| 144 · Notice of proposed sale | Jan 20, 2026 | Other filings | SEC |
| 5 · Annual statement of ownership | Jan 16, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 16, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jan 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 19, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 17, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 15, 2025 | Current report | SEC |
| 10-K · Annual report | Nov 25, 2025 | Annual report | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 6, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 5, 2025 | Results | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 21, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 20, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 18, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 16, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 9, 2025 | Material contract | SEC |
| 8-K · Current report | Sep 3, 2025 | Current report | SEC |
| 8-K · Current report | Aug 27, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Aug 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 18, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2025 | Results | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 22, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 3, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 24, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 18, 2025 | Other filings | SEC |
| 11-K · Annual report of an employee plan | Jun 17, 2025 | Annual report | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 9, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jun 6, 2025 | Material contract | SEC |
| 3 · Initial statement of ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 144 · Notice of proposed sale | May 29, 2025 | Other filings | SEC |
| 8-K · Current report | May 28, 2025 | Management or board change | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | May 28, 2025 | Big-stake notice | SEC |
| CERT · Exchange's certificate of listing | May 27, 2025 | Other filings | SEC |
| 8-A12B · Registration of shares for listing on an exchange | May 22, 2025 | Other filings | SEC |
| 8-K · Current report | May 22, 2025 | Material contract | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 20, 2025 | Other filings | SEC |
| 8-K · Current report | May 19, 2025 | Current report | SEC |
| 424B2 · Prospectus | May 19, 2025 | Offer document | SEC |
| 144 · Notice of proposed sale | May 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 19, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
This page holds 200 of 1,009 filings. Open Filings
Cap table
Built by 6ix from Cencora, Inc.’s releases · as of Jul 31, 2026
- Common shares
- 190,827,165
- Fully diluted
- 190,827,165
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 190,827,165 | Jul 31, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Jul 31, 2026 | 190,827,165 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Lori J. Ryerkerk Other companies: International Paper Company (Director · Since at least Jul 17, 2026); Norfolk Southern Corporation (Director · Since at least Jan 28, 2025); Eaton Corporation, PLC (Director · Since at least Apr 22, 2020); Celanese Corporation (Chairman and CEO, Director · May 1, 2019 – Feb 28, 2024 · Past); Axalta Coating Systems Ltd. (Director · Oct 30, 2015 – Feb 21, 2019 · Past); Hess Corporation (Senior Vice President · Nov 5, 2008 – Feb 4, 2009 · Past) | Director · Since at least Jun 1, 2025 |
| Dermot Mark Durcan Other companies: Veoneer Inc (VNE) (Director · Jun 12, 2018 – Apr 1, 2022 · Past); Advanced Micro Devices Inc (Director · Oct 30, 2017 – May 8, 2024 · Past); Freescale Semiconductor Ltd (Director · Aug 13, 2014 – Dec 7, 2015 · Past); MWI Veterinary Supply Inc (Director · Mar 5, 2014 – Feb 23, 2015 · Past); Micron Technology, Inc. (Chief Executive Officer, Director · Feb 13, 2006 – Oct 19, 2016 · Past) | Director · Since at least Sep 8, 2015 |
| Frank K. Clyburn Other companies: Kailera Therapeutics, Inc. (Director · Since at least Apr 16, 2026); Revolution Medicines, Inc. (Director · Since at least Aug 5, 2024); International Flavors & Fragrances, Inc. (Chief Executive Officer · Feb 14, 2022 – Mar 1, 2024 · Past); DuPont de Nemours, Inc. (Director · Jun 1, 2019 – Apr 28, 2021 · Past); Merck & Company, Inc. (EVP & Pres ? Human Health · Jan 1, 2019 – Oct 30, 2021 · Past) | Director · Since at least Oct 1, 2024 |
| Gregory D Wasson Other companies: P3 Health Partners Inc. (Director · Since at least Feb 9, 2021); OptimizeRx Corporation (Director · Since at least Jul 21, 2020); PNC Financial Services Group, Inc. (the) (Director · Jul 2, 2015 – Oct 1, 2018 · Past); Verizon Communications Inc. (Director · Mar 1, 2013 – Mar 6, 2018 · Past); Walgreen Company (President and CEO, Director · Apr 11, 2006 – Nov 12, 2014 · Past) | Director · May 15, 2014 – May 15, 2014 · Past |
| Kathleen W Hyle Other companies: X-Energy, Inc. (Director · Since at least Apr 24, 2026); ADT Inc. (Director · Sep 28, 2012 – May 2, 2016 · Past); Bunge Limited (Director · Jul 2, 2012 – Mar 2, 2020 · Past); Constellation Energy Corporation (Senior Vice President · Nov 11, 2008 – Mar 12, 2012 · Past) | Director · May 13, 2010 – Mar 11, 2024 · Past |
| Lon R Greenberg Other companies: Essential Utilities, Inc. (Director · Jun 1, 2012 – Sep 30, 2017 · Past); Ameriprise Financial, Inc. (Director · Apr 25, 2012 – Apr 27, 2022 · Past); AmeriGas Partners L.P (Director · Mar 21, 2012 – Dec 21, 2015 · Past); UGI Corporation (Director · Jan 1, 2012 – Jan 20, 2016 · Past) | Director · Since at least May 16, 2013 |
| Lorence H Kim Other companies: Revolution Medicines, Inc. (Director · Since at least Jul 12, 2022); Cowen Group Inc (Director · Feb 15, 2022 – Mar 1, 2023 · Past); Moderna, Inc. (Chief Financial Officer · Dec 7, 2018 – Jun 2, 2020 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 13, 2019 · Past) | Director · Since at least Oct 1, 2022 |
| Eva Boratto Other companies: Bath & Body Works, Inc. (Chief Financial Officer · Since at least Aug 1, 2023); United Parcel Service, Inc. (Director · Since at least Sep 10, 2020); CVS Health Corporation (EVP & CFO · Jul 10, 2013 – May 4, 2021 · Past) | Executive Vice President and Chief Financial Officer · Since at least Jun 29, 2026 |
| John Palumbo Other companies: DarioHealth Corp. (Chairman of the Board, Board Member · Since at least Apr 10, 2026); Lucid Diagnostics Inc. (Board Member · Since at least Sep 22, 2025) | Director · Apr 13, 2026 – Nov 5, 2026 · Past |
| Lauren M. Tyler Other companies: Centene Corporation (Director · Since Jun 19, 2026); Alleghany Corporation (Director · Jan 15, 2019 – Oct 19, 2022 · Past) | Director · Since at least Oct 1, 2023 |
All 47 people
| Person | Seat |
|---|---|
| Michael J Long Other companies: Mobix Labs, Inc. (Director · Since at least Jan 22, 2024); Arrow Electronics, Inc. (Executive Chairman, Director · Dec 31, 2005 – Mar 17, 2023 · Past) | Director · May 11, 2006 – Mar 5, 2023 · Past |
| Richard W Gochnauer Other companies: UGI Corporation (Director · Jan 20, 2011 – Jan 30, 2019 · Past); Essendant Inc (Chief Executive Officer, Director · Jan 1, 2009 – Mar 8, 2011 · Past) | Director · Sep 25, 2008 – Mar 11, 2024 · Past |
| Robert E. Sanchez Other companies: Ryder System, Inc. (Director · Since at least Feb 7, 2020); Texas Instruments Incorporated (Director · Since at least Jan 24, 2020) | Director · Since at least Sep 25, 2026 |
| Steven H Collis Other companies: Bausch + Lomb Corporation (Director · Since at least Jan 1, 2026); Elevance Health, Inc. (Director · Since at least Aug 1, 2025) | Executive Chairman, Director · Since at least Feb 1, 2006 |
| Charles H Cotros Other companies: Allied Waste Industries Inc (Director · May 25, 2006 – Dec 5, 2008 · Past) | Director · Jan 31, 2006 – Dec 7, 2012 · Past |
| Dennis M Nally Other companies: Morgan Stanley (Director · Since at least Oct 1, 2016) | Director · Since at least Jan 1, 2020 |
| Ellen Cooper Other companies: Lincoln National Corporation (Chairman, President & CEO, Director · Since at least Aug 6, 2012) | Director · Since at least Jan 20, 2026 |
| Henry Wadsworth McGee III Other companies: Tegna Inc (Director · Since at least Jun 29, 2015) | Director · Feb 1, 2006 – Mar 9, 2023 · Past |
| James F Cleary Jr Other companies: MWI Veterinary Supply Inc (President and CEO, Director · Sep 26, 2008 – Feb 23, 2015 · Past) | Chief Financial Officer · Since at least Mar 5, 2015 |
| J Lawrence Wilson Other companies: Cummins Inc. (Director · Mar 1, 2006 – Mar 2, 2009 · Past) | Director · Feb 1, 2006 – May 1, 2009 · Past |
| Joy Rowan Other companies: Merck & Company, Inc. (Senior Vice President of Sales · Apr 16, 2026 – Nov 5, 2026 · Past) | Senior Vice President of Sales · Apr 16, 2026 – Nov 5, 2026 · Past |
| Leslie Donato Other companies: Mallinckrodt Inc (Director · Since at least Jul 31, 2025) | Director · Aug 8, 2019 – Nov 5, 2026 · Past |
| Pawan Verma Other companies: Foot Locker Inc (EVP & Chief Info & Cust Conn · Aug 10, 2015 – Sep 28, 2020 · Past) | Executive Vice President and Chief Data and Information Officer · Since at least Oct 1, 2025 |
| Peyton Howell Other companies: Tandem Diabetes Care, Inc. (Director · Since at least Aug 3, 2020) | Executive Vice President · Feb 20, 2012 – Apr 4, 2018 · Past |
| Redonda Miller Other companies: Invivyd, Inc. (Director · Nov 19, 2021 – Jun 22, 2022 · Past) | Director · Since at least Jan 1, 2023 |
| Silvana Battaglia Other companies: Agilon Health, Inc. (Director · Since at least Jun 22, 2023) | Executive Vice President · Since at least May 16, 2019 |
| Sun Park Other companies: Tenet Healthcare Corporation (Executive Vice President & Chief Financial Officer · Since at least Jan 1, 2024) | Executive Vice President · May 20, 2016 – Nov 17, 2017 · Past |
| Dale Danilewitz | Executive Vice President · Nov 13, 2014 – May 23, 2019 · Past |
| Elizabeth Campbell | Executive Vice President · Since at least Nov 8, 2023 |
| François Mandeville | Executive Vice President and Chief Strategy and M&A Officer · Since at least Nov 5, 2026 |
| Gina Clark | Executive Vice President · Nov 13, 2014 – May 31, 2024 · Past |
| James Frary | Executive Vice President · Sep 23, 2010 – Nov 9, 2016 · Past |
| Jane E Md Henney | Director · Mar 1, 2021 – Mar 5, 2023 · Past |
| John G Chou | Executive Vice President · Nov 11, 2015 – Dec 20, 2021 · Past |
| Juan Guerra | Executive Vice President, Alliance Healthcare · Since at least Nov 4, 2026 |
| Lawrence Marsh | Executive Vice President · Nov 13, 2014 – Apr 29, 2016 · Past |
| Lazarus Krikorian | SVP & Chief Accounting Officer · Since at least Dec 5, 2014 |
| Matt Glucksmann | SVP and President, Health Systems · Since at least Nov 5, 2026 |
| Melissa O'Brien | Vice President, Investor Relations · Since at least Oct 2, 2026 |
| Michael D Dicandilo | Executive VP & CFO · Jan 30, 2006 – May 2, 2011 · Past |
| Richard Tremonte | EVP and President, Global Specialty Pharmaceuticals and Operations · Since at least Nov 4, 2026 |
| Robert P. Mauch | President and Chief Executive Officer · Since at least Nov 4, 2022 |
| Sam Hammock | Executive Vice President and Chief Human Resources Officer · Since at least Jun 15, 2026 |
| Terrance P Haas | Senior Vice President · Feb 8, 2006 – Feb 27, 2008 · Past |
| Tim Cernohous | Senior Vice President and President, Retail Pharmacy and Alternate Care · Since at least Nov 4, 2026 |
| Tim G Guttman | Chief Financial Officer · Feb 13, 2012 – Nov 9, 2018 · Past |
| Werner Baumann | Director · Since at least Oct 1, 2023 |
Log in to ask 6ix AI your own questions about Cencora, Inc.